Impact of Spinal Mobilizations on Pain Modulation in People With Low Back Pain.
Preliminary Neurophysiological Effects of Grade II Versus Grade IV Lumbar Spinal Mobilization in Adults With Mechanical Low Back Pain: A Pilot fMRI Crossover Study.
Research shows 85% of the population will experience at least one episode of low back pain (LBP) in their lifetime. The annual cost to manage LBP in the U.S. can exceed 2 billion dollars. A conservative approach to LBP management can be provided by a physical therapist through interventions such as spinal mobilization. Spinal mobilizations are graded (I-IV) based upon the varying depths and impulse frequency at which they are applied to the target tissue. Functional magnetic resonance imaging (fMRI) studies have shown that spinal mobilizations (grade III, grade V) can stimulate pain suppression and provide favorable neurophysiological effects on pain modulation.
No studies to date, however, have examined the neurophysiological influence of grades II and IV on pain modulation. The purpose of this study is to investigate the change in pain suppression following spinal mobilization (i.e., grades II and IV).
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Detaljert beskrivelse
A conservative approach to LBP management can be provided by a physical therapist through interventions such as spinal mobilization. Spinal mobilizations are defined as passive movements to the spinal joints at varying speeds and amplitudes to restore accessory motion and optimize joint function. Spinal mobilizations are graded (I-IV) based upon the varying depths and impulse frequency in which they are applied to the target tissue. Grades I and II are applied more superficially to the tissue just prior to the onset of tissue resistance. These grades are often used for pain modulation in individuals who report high levels of pain and may present as reactive and irritable. Grades III and IV are applied deeper into the tissue resistance and are primarily used to increase tissue extensibility and joint mobility. These grades are often used with individuals who primarily report stiffness and mobility loss with lower levels of pain.
A proposed mechanism associated with spinal mobilization is the neurophysiological influence on pain modulation through activation of descending inhibitory pathways. Functional magnetic resonance imaging (fMRI) studies have shown that spinal mobilizations (grade III, grade V) can stimulate the salience network and provide favorable neurophysiological effects on pain modulation. This is determined by measuring the change in peak blood-oxygen-level-dependent (BOLD) signal from predefined regions of interest (ROIs). These ROIs include the prefrontal cortex, precuneus, anterior/posterior insulas, thalamus, anterior/posterior cingulate cortices, somatosensory cortex, secondary somatosensory cortex, and periaqueductal gray. Computing correlations between region pairs will determine functional connectivity (FC) and show which brain regions are most active.
No studies to date have examined the neurophysiological influence of grades II or IV on the salience network stimulation and pain modulation. These grades vary greatly with respect to their frequency and depth of application but may still provide similar pain modulation outcomes. The purpose of this study is to investigate the change in salience network stimulation following spinal mobilization (i.e., grades II and IV).
Studietype
Studietype
Registrering (Antatt)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
Studiekontakt
- Navn: Mark Gugliotti, DPT
- Telefonnummer: 6315125559
- E-post: mgugliot@nyit.edu
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
A. New York Tech students B. Age range: at least 18 years old C. Good overall health D. Mechanical low back pain ≥ 1 month *(source of pain is muscular or skeletal) E. Pain intensity of at least 4/10 or greater
Exclusion Criteria:
A. Claustrophobia B. IEDs including: pacemakers, internal defibrillators, and insulin pumps C. Medical implants or metallic foreign bodies, not limited ferrous metals D. Any previous history of lumbar surgery, nerve root involvement, stenosis (narrowing of the spinal canal), or mechanical instability E. Pregnancy F. Use of opioid medication G. LBP secondary to disease or systemic cause H. History of cardiovascular disease or high blood pressure I. History of Type I or Type II Diabetes J. History of neurodevelopmental disorders K. Prolonged steroid* use *(e.g., prednisone, dexamethasone, hydrocortisone, etc.) L. Oswestry Low Back Disability Index (ODI) score of <5 M. Inability to provide informed consent
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Crossover-oppdrag
- Masking: Enkelt
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Eksperimentell: Grade II lumbar spine mobilization
A grade II posterior-to-anterior spinal mobilization will be applied to the individual's lumbar spine for a total of five minutes. |
A grade II spinal mobilization is applied to the spinal segment in a posterior-to-anterior direction to a tissue depth before the first onset of tissue resistance. |
|
Eksperimentell: Grade IV lumbar spinal mobiliation
A grade IV posterior-to-anterior spinal mobilization will be applied to the individual's lumbar spine for a total of five minutes. |
Grade IV central posterior-to-anterior spinal mobilization will be applied to the lumbar spine for five minutes to a tissue depth of 50% of the tissue resistance. |
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Numeric Pain Rating Scale
Tidsramme: At both sessions of care, from enrollment to the end of treatment at week 2
|
This 11-point numeric scale ranges from '0' representing one pain extreme (e.g., "no pain") to '10' representing the other pain extreme (e.g., "pain as bad as you can imagine" or "worst pain imaginable"). |
At both sessions of care, from enrollment to the end of treatment at week 2
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Etterforskere
Etterforskere
- Hovedetterforsker: Mark Gugliotti, DPT, NYIT
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Gay CW, Robinson ME, George SZ, Perlstein WM, Bishop MD. Immediate changes after manual therapy in resting-state functional connectivity as measured by functional magnetic resonance imaging in participants with induced low back pain. J Manipulative Physiol Ther. 2014 Nov-Dec;37(9):614-27. doi: 10.1016/j.jmpt.2014.09.001. Epub 2014 Oct 3.
- Zhou XC, Wu S, Wang KZ, Chen LH, Hong SW, Tian Y, Hu HJ, Lin J, Wei ZC, Xie YX, Yin ZH, Lv ZZ, Lv LJ. Default mode network and dorsal attentional network connectivity changes as neural markers of spinal manipulative therapy in lumbar disc herniation. Sci Rep. 2024 Nov 28;14(1):29541. doi: 10.1038/s41598-024-81126-2.
- Isenburg K, Mawla I, Loggia ML, Ellingsen DM, Protsenko E, Kowalski MH, Swensen D, O'Dwyer-Swensen D, Edwards RR, Napadow V, Kettner N. Increased Salience Network Connectivity Following Manual Therapy is Associated with Reduced Pain in Chronic Low Back Pain Patients. J Pain. 2021 May;22(5):545-555. doi: 10.1016/j.jpain.2020.11.007. Epub 2020 Dec 13.
- Chimenti RL, Frey-Law LA, Sluka KA. A Mechanism-Based Approach to Physical Therapist Management of Pain. Phys Ther. 2018 May 1;98(5):302-314. doi: 10.1093/ptj/pzy030.
- Bialosky JE, Beneciuk JM, Bishop MD, Coronado RA, Penza CW, Simon CB, George SZ. Unraveling the Mechanisms of Manual Therapy: Modeling an Approach. J Orthop Sports Phys Ther. 2018 Jan;48(1):8-18. doi: 10.2519/jospt.2018.7476. Epub 2017 Oct 15.
- Hanrahan S, Van Lunen BL, Tamburello M, Walker ML. The Short-Term Effects of Joint Mobilizations on Acute Mechanical Low Back Dysfunction in Collegiate Athletes. J Athl Train. 2005 Jun;40(2):88-93.
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Studiestart
Primær fullføring (Antatt)
Primær fullføring
Studiet fullført (Antatt)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
Andre studie-ID-numre
- NYIT IRB-2027-492
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .